share_log

RBC Capital Maintains Outperform on Moderna, Raises Price Target to $135

Benzinga ·  May 3 12:59

RBC Capital analyst Luca Issi maintains Moderna (NASDAQ:MRNA) with a Outperform and raises the price target from $125 to $135.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment